Poliovirus Surveillance: Building the Global Polio Laboratory Network

A network of virologic laboratories has been established by the World Health Organization to conduct surveillance for wild poliovirus and to provide evidence for the certification of poliomyelitis eradication. The network consists of >60 national laboratories isolating and identifying polioviruse...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 175; no. Supplement-1; pp. S113 - S116
Main Authors Hull, Barbara P., Dowdle, Walter R.
Format Journal Article
LanguageEnglish
Published United States The University of Chicago Press 01.02.1997
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A network of virologic laboratories has been established by the World Health Organization to conduct surveillance for wild poliovirus and to provide evidence for the certification of poliomyelitis eradication. The network consists of >60 national laboratories isolating and identifying polioviruses within countries; 16 regional reference laboratories, providing intratypic differentiation of wild and vaccine strains and assisting with quality assurance and training; and 6 global specialized laboratories, conducting research, preparing reference reagents, and providing genomic sequencing of wild polioviruses, advanced training, and expert virologic advice. Laboratories collaborate with national eradication programs in the detection, reporting, clinical investigation, and virologic testing of stool specimens obtained in connection with cases of acute flaccid paralysis and, where indicated, from healthy children and the environment. A quality assurance system, leading to World Health Organization accreditation, involves training in standardized techniques, use of centrally prepared typing antisera, annual proficiency testing and follow-up action, and monitoring of standard performance indicators.
Bibliography:ark:/67375/HXZ-BFS8D5L5-J
Reprints or correspondence: Dr. Barbara Hull, Global Programme for Vaccines and Immunization, World Health Organization, CH-1211 Geneva 27, Switzerland.
istex:EE4E7B7191D9E3CC9AB445B60A7DCF78334F2EC9
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/175.Supplement_1.S113